tiprankstipranks
Trending News
More News >
Restart Life Sciences (NMLSF)
OTHER OTC:NMLSF
Advertisement

Restart Life Sciences (NMLSF) Price & Analysis

Compare
30 Followers

NMLSF Stock Chart & Stats


NMLSF FAQ

What was Restart Life Sciences’s price range in the past 12 months?
Restart Life Sciences lowest stock price was $0.02 and its highest was $0.10 in the past 12 months.
    What is Restart Life Sciences’s market cap?
    Restart Life Sciences’s market cap is $2.42M.
      When is Restart Life Sciences’s upcoming earnings report date?
      Restart Life Sciences’s upcoming earnings report date is Aug 22, 2025 which is in 12 days.
        How were Restart Life Sciences’s earnings last quarter?
        Currently, no data Available
        Is Restart Life Sciences overvalued?
        According to Wall Street analysts Restart Life Sciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Restart Life Sciences pay dividends?
          Restart Life Sciences does not currently pay dividends.
          What is Restart Life Sciences’s EPS estimate?
          Restart Life Sciences’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Restart Life Sciences have?
          Restart Life Sciences has 33,230,354 shares outstanding.
            What happened to Restart Life Sciences’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Restart Life Sciences?
            Currently, no hedge funds are holding shares in NMLSF

            Company Description

            Restart Life Sciences

            Nova Mentis Life Science Corp., through its subsidiaries, engages in developing diagnostics and psilocybin based therapeutics for neuroinflammatory conditions with a focus on autism spectrum disorder and fragile X syndrome in Canada. It is also involved in the research and development of anti-inflammatory effects of psilocybin for metabolic indications, such as obesity and diabetes; and development of cannabis products. Nova Mentis Life Science Corp. has a research agreement with the University of Central Florida (UCF) to develop a saliva serotonin assay. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada.

            Restart Life Sciences (NMLSF) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Cybin
            Braxia Scientific
            Entheon Biomedical
            Doseology Sciences
            GeneTether Therapeutics, Inc.

            Ownership Overview

            20.47%79.53%
            20.47% Insiders
            ― Other Institutional Investors
            79.53% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis